Nova Patents
AT294238T

Recombinant toxin fragments

Abstract

(57) summary polypeptide. Whether polypeptide makes it possible to be conveyed into a target cell, and Or it has the 1st and 2nd domains that enable polypeptide to make the solubility of polypeptide increase, or to be the both and to cut one or more small granule vesicles indispensable to エキソサイ ptosis or protoplasmic membrane interacting protein. Therefore, polypeptide combines the useful characteristic of a clostridial toxin (for example, a Botulin toxin or a tetanus toxin) without the toxicity followed on a natural molecule. Polypeptide target-izes it into a specific cell, and may include again the 3rd domain that makes polypeptide useful in prevention of the エキソサイ ptosis in a target cell. Fused protein containing polypeptide, the nucleic acid which carries out the code of the polypeptide, and the method of producing polypeptide are also offered. The activation by which polypeptide was controlled is possible, and polypeptide may be included in a vaccine and toxin assay.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

49 members in 11 offices

This recordMember, by publication datePriority claim1 more office is in the list below

Priority claims3

Priority claims
DocumentOfficeKindDate
9617671United KingdomA
9625996United KingdomA
9702273United KingdomW

Members49

Family members, oldest first
DocumentOfficeKind
GB9617671D0United KingdomD0
GB9625996D0United KingdomD0
CA2264191A1CanadaA1
WO9807864A1World Intellectual Property Organization (WIPO)A1
AU4389597AAustraliaA
ZA977541BSouth AfricaB
EP0939818A1European Patent Office (EPO)A1
AU723397B2AustraliaB2
JP2001502890AJapanA
US2002044950A1United States of AmericaA1
US6461617B1United States of AmericaB1
US2003166238A1United States of AmericaA1
CA2498502A1CanadaA1
WO2004024909A2World Intellectual Property Organization (WIPO)A2
AU2003267559A1AustraliaA1
WO2004024909A3World Intellectual Property Organization (WIPO)A3
EP0939818B1European Patent Office (EPO)B1
AT294238TThis recordAustriaT
ATE294238T1AustriaT1
DE69733146D1GermanyD1
EP1537207A2European Patent Office (EPO)A2
DK0939818T3DenmarkT3
US2005244435A1United States of AmericaA1
JP2005537809AJapanA
DE69733146T2GermanyT2
US2006110410A1United States of AmericaA1
US7192596B2United States of AmericaB2
US2007184070A1United States of AmericaA1
US2007248626A1United States of AmericaA1
AU2003267559B2AustraliaB2
JP4273250B2JapanB2
US2009148888A1United States of AmericaA1
US2009246827A1United States of AmericaA1
US2009274708A1United States of AmericaA1
US2010022751A1United States of AmericaA1
US7674470B2United States of AmericaB2
EP2280066A2European Patent Office (EPO)A2
US2011028691A1United States of AmericaA1
US7897158B2United States of AmericaB2
JP2011045377AJapanA
EP2280066A3European Patent Office (EPO)A3
US8012479B2United States of AmericaB2
US8012491B2United States of AmericaB2
US8017134B2United States of AmericaB2
CA2264191CCanadaC
US8454976B2United States of AmericaB2
CA2498502CCanadaC
JP5570936B2JapanB2
US9006395B2United States of AmericaB2